NCT01171105View on ClinicalTrials.gov

Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Healthy
Interventions
DRUG

AZD5213

oral solution, multiple ascending doses

DRUG

Placebo to AZD5213

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY